Connect with us


Enzymatica shares jump as company says mouth spray can deactivate COVID-19 – MarketWatch



post featured image

Shares of Enzymatica
jumped 67% in Stockholm as the company said preliminary results show the ability of the mouth spray ColdZyme, in vitro, to deactivate SARS-CoV-2, the virus causing the COVID-19 pandemic. The study demonstrated that ColdZyme deactivates SARS-CoV-2 coronavirus by 98.3%, the company said. “Even if the current in vitro results cannot be directly translated into clinical efficacy, it is very interesting that ColdZyme is able to effectively deactivate SARS-CoV-…

Click here to view the original article.

Continue Reading

You might also like ...

post featured image
Summit County’s COVID-19 positivity rate drops as testing efforts increase across the county – Summit Daily News
post featured image
Broader stay-at-home order is likely for L.A. County – Los Angeles Times
post featured image
El Paso County begins moving mobile morgues to new central location – KVIA El Paso